Key products

Carboprost Trometamol

Carboprost Trometamol

Specification:250ug (Formulation strength)

Composition:

Description:

Storage:

Indications:
1.Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity; 3. Requirement of a repeat intrauterine instillation of drug for expulsion of the fetus; 4. Inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion

Pharmacopeia:

DMF:

GMP:

Origin:India

Batch Size:100g

Registration status:
FDA:27865    A
EU:√  
CDE: Y20200000103  I

Advantage:
The only approved API used in US listed generic drugs
Exclusive API, independent review in CDE